Network-based characterization of drug-regulated genes, drug targets, and toxicity

被引:68
|
作者
Kotlyar, Max [1 ]
Fortney, Kristen [2 ]
Jurisica, Igor [1 ,2 ,3 ,4 ]
机构
[1] Univ Hlth Network, IBM Life Sci Discovery Ctr, Ontario Canc Inst, Campbell Family Inst Canc Res, Toronto, ON M5G 1L7, Canada
[2] Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada
[3] Univ Hlth Network, Techna Inst, Toronto, ON M5G 1L7, Canada
[4] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3H5, Canada
基金
加拿大创新基金会;
关键词
Protein-protein interactions; Drug development; Transcription regulation; Drug cytotoxicity; PROTEIN-INTERACTION NETWORKS; PREDICTIVE TOXICOLOGY; INTERACTION DATABASE; DISEASE; DISCOVERY; CANCER; CLASSIFICATION; CYTOTOXICITY; COMBINATIONS; INFORMATION;
D O I
10.1016/j.ymeth.2012.06.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Proteins do not exert their effects in isolation of one another, but interact together in complex networks. In recent years, sophisticated methods have been developed to leverage protein-protein interaction (PPI) network structure to improve several stages of the drug discovery process. Network-based methods have been applied to predict drug targets, drug side effects, and new therapeutic indications. In this paper we have two aims. First, we review the past contributions of network approaches and methods to drug discovery, and discuss their limitations and possible future directions. Second, we show how past work can be generalized to gain a more complete understanding of how drugs perturb networks. Previous network-based characterizations of drug effects focused on the small number of known drug targets, i.e., direct binding partners of drugs. However, drugs affect many more genes than their targets - they can profoundly affect the cell's transcriptome. For the first time, we use networks to characterize genes that are differentially regulated by drugs. We found that drug-regulated genes differed from drug targets in terms of functional annotations, cellular localizations, and topological properties. Drug targets mainly included receptors on the plasma membrane, down-regulated genes were largely in the nucleus and were enriched for DNA binding, and genes lacking drug relationships were enriched in the extracellular region. Network topology analysis indicated several significant graph properties, including high degree and betweenness for the drug targets and drug-regulated genes, though possibly due to network biases. Topological analysis also showed that proteins of down-regulated genes appear to be frequently involved in complexes. Analyzing network distances between regulated genes, we found that genes regulated by structurally similar drugs were significantly closer than genes regulated by dissimilar drugs. Finally, network centrality of a drug's differentially regulated genes correlated significantly with drug toxicity. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:499 / 507
页数:9
相关论文
共 50 条
  • [21] Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC
    Wang, Chun-, I
    Chu, Pei-Ming
    Chen, Yi-Li
    Lin, Yang-Hsiang
    Chen, Cheng-Yi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [22] Assessment of key regulatory genes and identification of possible drug targets for Leprosy (Hansen's disease) using network-based approach
    Khan, Mahvish
    Khan, Saif
    Lohani, Mohtashim
    Ahmed, Mohd Murshad
    Sharma, Diksha
    Ishrat, Romana
    Ahmad, Saheem
    Sherwani, Subuhi
    Haque, Shafiul
    Bhagwath, Sundeep S.
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2023, 39 (02) : 1143 - 1162
  • [23] Network-based technologies for early drug discovery
    Fotis, Chris
    Antoranz, Asier
    Hatziavramidis, Dimitris
    Sakellaropoulos, Theodore
    Alexopoulos, Leonidas G.
    DRUG DISCOVERY TODAY, 2018, 23 (03) : 626 - 635
  • [24] Protein Structure Network-based Drug Design
    Liang, Zhongjie
    Hu, Guang
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2016, 16 (16) : 1330 - 1343
  • [25] A review of network-based approaches to drug repositioning
    Shahreza, Maryam Lotfi
    Ghadiri, Nasser
    Mousavi, Sayed Rasoul
    Varshosaz, Jaleh
    Green, James R.
    BRIEFINGS IN BIOINFORMATICS, 2018, 19 (05) : 878 - 892
  • [26] Network-based in silico drug efficacy screening
    Emre Guney
    Jörg Menche
    Marc Vidal
    Albert-László Barábasi
    Nature Communications, 7
  • [27] Network-Based Methods and Their Applications in Drug Discovery
    Yu, Zhuohang
    Wu, Zengrui
    Wang, Ze
    Wang, Yimeng
    Zhou, Moran
    Li, Weihua
    Liu, Guixia
    Tang, Yun
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 64 (01) : 57 - 75
  • [28] Network-Based Inference Methods for Drug Repositioning
    Chen, Hailin
    Zhang, Heng
    Zhang, Zuping
    Cao, Yiqin
    Tang, Wenliang
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2015, 2015
  • [29] Network-based in silico drug efficacy screening
    Guney, Emre
    Menche, Joerg
    Vidal, Marc
    Barabasi, Albert-Laszlo
    NATURE COMMUNICATIONS, 2016, 7
  • [30] A network-based phenotype mapping approach to identify genes that modulate drug response phenotypes
    Cairns, Junmei
    Ung, Choong Yong
    da Rocha, Edroaldo Lummertz
    Zhang, Cheng
    Correia, Cristina
    Weinshilboum, Richard
    Wang, Liewei
    Li, Hu
    SCIENTIFIC REPORTS, 2016, 6